TWD
HUMA icon

True Wealth Design’s Humacyte HUMA Stock Holding History

True Wealth Design’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
1,286
+141
+12% +$131 ﹤0.01% 1976
2026
Q1 		$695 Buy
+1,145
New +$1.19K ﹤0.01% 1930
2025
Q3 		– Sell
-259
Closed -$542 – 2795
2025
Q2 		$542 Buy
259
+249
+2,490% +$478 ﹤0.01% 1708
2025
Q1 		$18 Buy
+10
New +$38 ﹤0.01% 2600

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

True Wealth Design's HUMA Position: Q2 2026 in Review

True Wealth Design increased its Humacyte (HUMA) stake by 12% in Q2 2026, buying an estimated $131 and bringing the position to 1,286 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

True Wealth Design first reported a position in HUMA in Q1 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • True Wealth Design held 1,286 shares of Humacyte worth $1K as of Q2 2026.
  • True Wealth Design bought 141 Humacyte shares in Q2 2026, an estimated $131.
  • Humacyte made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1976 holding.
  • True Wealth Design first reported a position in Humacyte in Q1 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.